MedPath

KING FAISAL UNIVERSITY

🇸🇦Saudi Arabia
Ownership
-
Established
1975-01-01
Employees
-
Market Cap
-
Website
http://www.kfu.edu.sa

Clinical Trials

11

Active:0
Completed:8

Trial Phases

3 Phases

Phase 1:4
Phase 2:4
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Phase 1
4 (40.0%)
Phase 2
4 (40.0%)
Not Applicable
2 (20.0%)

The Impact of High-Fat Ketogenic Diet and Low-Fat Diet in Women Body Weight

Not Applicable
Recruiting
Conditions
Healthy
Overweight and Obesity
First Posted Date
2023-04-13
Last Posted Date
2023-06-12
Lead Sponsor
King Faisal University
Target Recruit Count
28
Registration Number
NCT05811702
Locations
🇸🇦

Randah Alqurashi, Riyadh, Saudi Arabia

Non-dependent HFPPV Versus CPAP for Video-assisted Thoracoscopy

Phase 2
Completed
Conditions
Elective Video-assisted Thoracoscopic Surgery
One-lung Ventilation Lasts at Least One Hour
First Posted Date
2010-12-07
Last Posted Date
2010-12-08
Lead Sponsor
King Faisal University
Target Recruit Count
30
Registration Number
NCT01254786
Locations
🇸🇦

King Fahd hospital of the University of Dammam, Al Khubar, Eastern, Saudi Arabia

Cerebral Oxygenation After Lung Resection

Phase 1
Completed
Conditions
Elective
Lung Resection
Surgery
First Posted Date
2010-08-18
Last Posted Date
2012-03-26
Lead Sponsor
King Faisal University
Target Recruit Count
120
Registration Number
NCT01183871
Locations
🇸🇦

King Fahd hospital of the University of Dammam, Al Khubar, Eastern, Saudi Arabia

The Effects of Hyperventilation Prior to CO2 Insufflation During Laparoscopic Cholecystectomy

Phase 1
Completed
Conditions
Laparoscopic Cholecystectomy
First Posted Date
2010-08-17
Last Posted Date
2010-11-19
Lead Sponsor
King Faisal University
Target Recruit Count
100
Registration Number
NCT01182545
Locations
🇸🇦

King Faisal University, Al Khubar, Eastern, Saudi Arabia

In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

Suspended
Conditions
Infections, Bacterial
Interventions
Drug: In Vitro activity of Tigecycline among key bacterial pathogens exhibiting multidrug resistance
First Posted Date
2010-05-28
Last Posted Date
2011-06-23
Lead Sponsor
King Faisal University
Target Recruit Count
500
Registration Number
NCT01132417
Locations
🇸🇦

King Faisal Univrsity, Departmentof Microbiology and Immunology,, dammam branh, Dammam, Eastern, Saudi Arabia

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.